MAST Trial: Investigating Metformin's Role in Prostate Cancer Active Surveillance - Anthony Joshua
Anthony Joshua
Anthony Joshua presents the findings of the MAST trial, a decade-long investigation into the use of metformin for men with low-risk prostate cancer under active surveillance.
Predictive Markers in Metastatic Prostate Cancer: Insights from the VISION Trial - Oliver Sartor
Oliver Sartor
Evan Yu and Oliver Sartor discuss the VISION trial's exploration of predictive and prognostic markers in the treatment of prostate cancer with Lutetium-PSMA-617.